The ROS controversy in hypoxic pulmonary hypertension revisited
Eur Respir J
.
2018 Mar 8;51(3):1800276.
doi: 10.1183/13993003.00276-2018.
Print 2018 Mar.
Authors
Sébastien Bonnet
1
2
,
Olivier Boucherat
1
2
Affiliations
1
Pulmonary Hypertension Research Group, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada.
2
Dept of Medicine, Université Laval, Québec, QC, Canada.
PMID:
29519907
DOI:
10.1183/13993003.00276-2018
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antioxidants*
Humans
Hypertension, Pulmonary
Hypoxia
Mitochondria
Reactive Oxygen Species*
Substances
Antioxidants
Reactive Oxygen Species